Table 2.

Commercial liposome-based drug delivery systems.

product name	encapsulated drug	approved treatment
Myocet	doxorubicin	metastatic breast cancer [95]
Doxil	doxorubicin	Kaposi's sarcoma, ovarian and breast cancer [96–98]
Lipodox	doxorubicin	Kaposi's sarcoma, ovarian and breast cancer [99]
Marqibo	vincristine sulfate	acute lymphoblastic leukaemia [100]
DaunoXome	daunorubicin	blood tumours [101]
Epaxal	inactivated hepatitis A virus	hepatitis A [102]
DepoDur	morphine sulfate	pain management [103]
DepoCyt	cytarabine	neoplastic meningitis and lymphomatous meningitis [104]